Many Clinicians Take Wait-and-See Attitude to New Dry Eye Drug

Most clinicians were unfamiliar with lifitegrast (Xiidra) in a recent Medscape survey. The July FDA approval of the drug brings competition for the condition's best-known brand.
Medscape Medical News

Full Story →